SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Florida enthusiastically welcomes Calcalist conference to Miami

Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management

Full list of Israeli startup M&As in 2024

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

Buzz

Most popular

Daily

Weekly

1

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

2

Is your solitaire opponent actually a bot?

3

Cloudera acquires Israeli startup Octopai to advance metadata and AI integration

4

Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl

5

CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments

Kadimastem

2 stories about Kadimastem

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer

Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer

The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019